Search

everythinglearnresearchcommunity

for

Search:↓

Black women's unique hair characteristics and styling practices can lead to specific scalp conditions, which require early diagnosis and appropriate treatment.

Most hair loss can be diagnosed with patient history and physical exam, and a few common types make up most cases.

The study concluded that severity of Frontal fibrosing alopecia is not linked to how long someone has it, can start before menopause, and eyebrow loss may be an early sign.

The conclusion is that primary scarring alopecia is a complex condition that requires early and accurate diagnosis for effective treatment.

The authors suggest that a new type of hair loss exists, which is different from alopecia areata.

Low-level laser therapy can stimulate hair growth more effectively than fake devices, but patient satisfaction is similar for both. Results should be taken with caution due to small study sizes and differences between studies. More research is needed.

Recognize and treat hair loss conditions that mimic androgenetic alopecia by identifying warning signs and using proper tools.

The conclusion is that accurately identifying folliculosebaceous tumors requires understanding their clinical signs and microscopic features.

Fat tissue transplant may be an effective new treatment for severe, treatment-resistant hair loss from folliculitis decalvans.

The dog with an Alopecia Areata-like condition showed signs of an autoimmune disease and partially regrew hair without treatment, suggesting dogs could be models for human AA research.

Hair health depends on various factors and hair loss can significantly affect a person's well-being; understanding hair biology is key for creating effective hair care treatments.

Erdr1 could be a new marker for diagnosing hair loss.

The document concludes that treatments for cicatricial alopecia are not well-supported by evidence, but hair transplantation shows more predictable and satisfactory results.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

The document concludes that proper diagnosis and management of hair loss in children require a detailed examination and understanding of various hair disorders.

The document reviews various hair and nail disorders, their causes, and treatments, emphasizing the need for proper diagnosis and the link between nail changes and systemic diseases.

The trichoscopy-assisted hair pull test is useful for diagnosing different types of hair loss.

A rare skin disorder, nevus comedonicus, can appear on one side of the body following Blaschko's lines.

Understanding hair structure and growth is key for diagnosing hair diseases accurately.

Male-pattern hair loss is normal, often involves hormone effects on hair follicles, and can be treated with medication or surgery, but new treatments are being researched.

Cicatricial alopecia causes permanent hair loss and is treated to relieve symptoms and stop progression.

Hair loss in African American women, caused by hair care, genetics, and environment, needs more research for better treatment.

The treatment helped reduce symptoms and stabilize the hairline in most patients with Frontal Fibrosing Alopecia, but hair regrowth was limited.

Lichen planopilaris is a chronic, scarring hair loss condition with no definitive cure, requiring accurate diagnosis and treatment to manage symptoms.

The cause of Frontal Fibrosing Alopecia is unclear, diagnosis involves clinical evaluation and various treatments exist, but their effectiveness is uncertain.

The conclusion is that acne, alopecia, and hyperhidrosis are common skin issues with various treatments available, and accurate diagnosis is key for effective management.

A systematic approach is crucial for managing hair loss in women.

Hair and nail changes can indicate health issues, including cancer and side effects from cancer treatments.

Black dots under trichoscopy can appear in different hair and scalp conditions, not just in alopecia areata.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.